Found: 17
Select item for more details and to access through your institution.
Applying a conceptual model for examining health-related quality of life in long-term breast cancer survivors: CALGB study 79804.
- Published in:
- Psycho-Oncology, 2008, v. 17, n. 11, p. 1108, doi. 10.1002/pon.1329
- By:
- Publication type:
- Article
Long-term outcomes of patients with recurrent ovarian cancer treated with a polyvalent vaccine with bevacizumab combination.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 1, p. 183, doi. 10.1007/s00262-022-03225-1
- By:
- Publication type:
- Article
A phase 1 study of KOS-862 (Epothilone D) co-administered with carboplatin (Paraplatin(R)) in patients with advanced solid tumors.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Economic outcomes of breast cancer survivorship: CALGB study 79804.
- Published in:
- Breast Cancer Research & Treatment, 2005, v. 91, n. 2, p. 153, doi. 10.1007/s10549-004-6497-9
- By:
- Publication type:
- Article
Options for Adjuvant Therapy for Uterine Leiomyosarcoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Epithelial ovarian cancer.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Ovarian carcinoma screening in women at intermediate risk: Impact on quality of life and need for invasive follow‐up.
- Published in:
- Cancer (0008543X), 2005, v. 104, n. 2, p. 314, doi. 10.1002/cncr.21148
- By:
- Publication type:
- Article
Overall survival and histology-specific subgroup analyses from a phase 3, randomized controlled study of trabectedin or dacarbazine in patients with advanced liposarcoma or leiomyosarcoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
External validation of a prognostic nomogram for overall survival in women with uterine leiomyosarcoma.
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 10, p. 1816, doi. 10.1002/cncr.27971
- By:
- Publication type:
- Article
Adjuvant therapy for high-grade, uterus-limited leiomyosarcoma: Results of a phase 2 trial (SARC 005)
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Adjuvant therapy for high-grade, uterus-limited leiomyosarcoma.
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 8, p. 1555, doi. 10.1002/cncr.27942
- By:
- Publication type:
- Article
Eribulin mesylate (halichondrin B analog E7389) in platinum-resistant and platinum-sensitive ovarian cancer: a 2-cohort, phase 2 study.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Eribulin mesylate (halichondrin B analog E7389) in platinum-resistant and platinum-sensitive ovarian cancer.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 9, p. 2403, doi. 10.1002/cncr.26569
- By:
- Publication type:
- Article
A nomogram to predict postresection 5-year overall survival for patients with uterine leiomyosarcoma.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 3, p. 660, doi. 10.1002/cncr.26333
- By:
- Publication type:
- Article
A Phase II Trial of Sorafenib and Dacarbazine for Leiomyosarcoma, Synovial Sarcoma, and Malignant Peripheral Nerve Sheath Tumors.
- Published in:
- Oncologist, 2019, v. 24, n. 6, p. 857, doi. 10.1634/theoncologist.2018-0160
- By:
- Publication type:
- Article
Altered regional homogeneity in patients with ovarian cancer treated with chemotherapy: a resting state fMRI study.
- Published in:
- Brain Imaging & Behavior, 2022, v. 16, n. 2, p. 539, doi. 10.1007/s11682-021-00525-5
- By:
- Publication type:
- Article
Phase 2 study of LY3023414 in patients with advanced endometrial cancer harboring activating mutations in the PI3K pathway.
- Published in:
- 2020
- By:
- Publication type:
- journal article